Aerovate Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.867; its P/E ratio is -7.59; Aerovate Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -20.58M	$ -19.59M	$ -19.05M	$ -17.38M	$ -15.80M
EBITDA	$ -21.49M	$ -20.37M	$ -19.66M	$ -18.02M	$ -16.37M
Net Income Common Stockholders	$ -20.63M	$ -19.59M	$ -19.02M	$ -16.25M	$ -14.72M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 122.44M	$ 135.20M	$ 150.10M	$ 118.93M	$ 129.22M
Total Assets	$ 127.42M	$ 140.88M	$ 155.75M	$ 124.13M	$ 135.30M
Total Debt	$ 675.00K	$ 809.00K	$ 855.00K	$ 964.00K	$ 1.09M
Net Debt	$ -121.76M	$ -134.39M	$ -149.24M	$ -117.97M	$ -128.13M
Total Liabilities	$ 17.96M	$ 15.15M	$ 13.83M	$ 11.30M	$ 8.56M
Stockholders Equity	$ 109.46M	$ 125.72M	$ 141.93M	$ 113.09M	$ 126.74M
Cash Flow	-
Free Cash Flow	$ -14.86M	$ -15.64M	$ -14.97M	$ -11.44M	$ -14.87M
Operating Cash Flow	$ -14.80M	$ -15.61M	$ -14.94M	$ -11.42M	$ -14.87M
Investing Cash Flow	$ 5.65M	$ -13.13M	$ 3.98M	$ 15.38M	$ 14.49M
Financing Cash Flow	$ 463.00K	$ 20.00K	$ 45.29M	$ 223.00K	$ 357.00K

Currency in USD

Aerovate Therapeutics Earnings and Revenue History

Income Statement >

Aerovate Therapeutics Debt to Assets

Balance Sheet >

Aerovate Therapeutics Cash Flow

Cash Flow >

Aerovate Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing